Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study. (2022)

First Author: Martin P
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.lanepe.2022.100478

PubMed Identifier: 36105885

Publication URI: http://europepmc.org/abstract/MED/36105885

Type: Journal Article/Review

Volume: 21

Parent Publication: The Lancet regional health. Europe

ISSN: 2666-7762